Targeted therapies: Using β-blockers to inhibit breast cancer progression (Q84639335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

title

Targeted therapies: Using β-blockers to inhibit breast cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Desmond G Powe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

Frank Entschladen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

publication date

2 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

511-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

Aspirin use, colorectal cancer survival, and loss to follow-up

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

The sympathetic nervous system induces a metastatic switch in primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

Beta-adrenergic signaling, a novel target for cancer therapy?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21808268

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21808268

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2011.123

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2011.123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808268 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference